lunes, 27 de junio de 2016

HHS calls on center for innovation to accelerate Zika vaccine development

Dept. of Health & Human Services

HHS calls on center for innovation to accelerate Zika vaccine development

June 27, 2016 
To accelerate development of a Zika vaccine, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) will begin developing a vaccine using its Center for Innovation in Advanced Development and Manufacturing (CIADM) in Baltimore, Maryland.
With funding and direction from ASPR’s Biomedical Advanced Research and Development Authority (BARDA), the CIADM led by Emergent BioSolutions, Inc., will conduct a variety of studies to move quickly through early stages of vaccine development and submit an investigational new drug request to FDA to begin clinical studies. To further speed development time, the CIADM will use vaccine technology similar to that used in vaccines being developed to protect against similar viruses, such as Dengue.
Read more about today's announcement.
Tweet This

No hay comentarios: